What is bubonic plague? History, causes, symptoms as Arizona's Coconino County reports first ‘Black Death' since 2007
According to the officials, the incident has nothing to do with a recent prairie dog die-off in the region.
Authorities from Coconino County Health and Human Services stated in a statement that the person's death is the first pneumonic plague mortality in the county since 2007.
The patient suffered from Yersinia pestis, the plague-causing bacteria, according to Northern Arizona Healthcare, which was determined by the Arizona Department of Health Services through rapid diagnostic testing.
Also Read: Trump's frightening 7-word to Melania revealed by lip leader as they visit flood-stricken Texas; 'Look at how…'
Bubonic plague history
Historically, the plague has been linked to Europe's Middle Ages, when it was widespread and caused one of the bloodiest outbreaks in the continent's history. It is also called 'The Black Death.'
According to Centers for Disease Control and Prevention data, there have been an average of seven cases of bubonic plague reported every year since 2000, making instances of the disease exceedingly uncommon in the US. Deaths from the plague are much less common; and the last one occurred in the US in 2021.
The majority of documented cases, however, originate from the southwestern states of Arizona, New Mexico, southern Colorado, Nevada, California, and southern Oregon.
Bubonic plague: Causes and symptoms
The CDC report stated that fleas and wild rodents are the carriers of the bacteria responsible for the plague, which is typically contracted by coming in contact with an infected animal or by being bitten by an infected rodent flea.
Fever, headaches, chills, weakness, and one or more swollen, sore lymph nodes are typical symptoms, as per the CDC.
Bubonic plague: Prevention
If detected and treated early, the illness can be managed with appropriate antibiotic therapy and can become pneumonic (affecting the lungs) or septicemic (spreading throughout the bloodstream), stated health officials.
In a bid to prevent exposure to plague, one should avoid contact with wild animals and fleas and take sick pets to the clinic.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
U.S. aid cuts halt HIV vaccine research in South Africa, with global impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived. Stop all work, it said. The United States under the Trump administration was withdrawing all its funding. The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere. But the $46 million from the U.S. for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home. South Africa has been hit especially hard because of Mr. Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR. Now that's gone. Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the future. Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans. 'We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer,' Ms. Gray said. She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant. A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials. Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job. Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%. 'It's very sad and devastating, honestly," she said of the U.S. cuts and overall uncertainty. 'We'll also miss out collaborating with other scientists across the continent.' Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response. But now that momentum, he said, has 'all kind of had to come to a halt.' The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk. South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis — another disease with a high number of cases in the country. South Africa's government has said it will be very difficult to find funding to replace the U.S. support. And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities. For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools. During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large. Other countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said. 'But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding," Byanyima said.
Time of India
2 hours ago
- Time of India
Fentanyl crisis takes center stage in US-China trade negotiations: Here's why
Trade policy as a weapon against Fentanyl China's response and diplomatic tensions Live Events Fentanyl's role in trade talks The stakes US Customs and Border Protection (CBP) reports that seizures of fentanyl at the border have doubled in the past two years, yet the supply remains robust, fueling the urgency behind the US's hardline stance. The ongoing dispute threatens to disrupt global supply chains, with the fentanyl crisis now influencing tariffs on a wide range of goods, from electronics to pharmaceuticals. The August 14 window is critical: if no further agreement is reached, tariffs could snap back to higher levels, with the fentanyl tariff remaining a central point of contention. (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The ongoing US-China trade talks have placed fentanyl—a deadly synthetic opioid—at the heart of economic diplomacy, underscoring how a public health emergency has become a central bargaining chip in global commerce. The Trump administration has repeatedly accused China of enabling the flow of fentanyl and its chemical precursors into the United States, leading to a surge in overdose deaths and prompting unprecedented tariffs that have reshaped the trade is a synthetic opioid up to 50 times stronger than heroin and 100 times more potent than morphine. Just 2 milligrams—an amount smaller than a few grains of sand—can cause a fatal overdose. The US has faced a relentless wave of fentanyl-related deaths, with tens of thousands of Americans dying annually from overdoses linked to the drug and its analogues. The Centers for Disease Control and Prevention (CDC) estimates that synthetic opioids , primarily fentanyl, are responsible for over 70,000 overdose deaths in the US each response to the crisis, President Trump stated an emergency and imposed a 20% "fentanyl tariff" on all Chinese imports, explicitly linking trade penalties to China's alleged failure to stem the flow of fentanyl precursors to Mexican drug cartels , which then traffic the drug into the US. This fentanyl tariff remains in place even as broader tariffs have been temporarily reduced following recent trade negotiations.'The flow of contraband drugs like fentanyl to the United States, through illicit distribution networks, has created a national emergency, including a public health crisis. Chinese officials have failed to take the actions necessary to stem the flow of precursor chemicals to known criminal cartels,' stated the White has pushed back, arguing that the US opioid crisis is rooted in domestic misuse and regulatory failures, not Chinese exports. Still, in a move seen as a gesture of goodwill, China recently tightened controls on two key chemicals used in fentanyl production, adding them to a list of strictly regulated 4-ANPP and NPP are widely recognized as the most immediate precursors used in illicit fentanyl synthesis. Chinese authorities have also added other related substances to their control lists in line with United Nations recommendations, and are working to schedule additional chemicals such as 4-piperidone and officials, however, maintain that the ultimate responsibility lies with the US:'Fentanyl is the U.S.'s problem, not China's. The responsibility to resolve this issue lies with the United States,' said Guo Jiakun, spokesperson for China's Foreign 20% fentanyl tariff is now a sticking point in ongoing negotiations. While both countries have agreed to temporarily lower other tariffs, the fentanyl-related duties remain, reflecting the issue's political and public health gravity. The US insists that further progress on trade depends on China's willingness to clamp down on fentanyl precursors, while China views the tariff as punitive and based on a mischaracterization of the crisis.
Indian Express
2 hours ago
- Indian Express
US aid cuts halt HIV vaccine research in South Africa, with global impact
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived. Stop all work, it said. The United States under the Trump administration was withdrawing all its funding. The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere. But the $46 million from the US for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home. South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR. Now that's gone. Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the future. Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans. 'We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer,' Gray said. She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant. A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials. Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job. Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%. 'It's very sad and devastating, honestly,' she said of the U.S. cuts and overall uncertainty. 'We'll also miss out collaborating with other scientists across the continent.' Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response. But now that momentum, he said, has 'all kind of had to come to a halt.' The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk. South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis — another disease with a high number of cases in the country. South Africa's government has said it will be very difficult to find funding to replace the U.S. support. And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities. For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools. During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large. Other countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said. 'But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding,' Byanyima said.
